IDO1 and colonic neoplasm: The study demonstrated that either 1-MT or EGCG significantly attenuated IDO activity in serum and suppressed IDO-overexpressing pre-neoplastic lesions in the colorectum of an AOM-induced rat colon cancer model [93].